Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...
clearance of the customized surgery planning software co-developed by both companies. On September 1 st, 2023, NuVasive was acquired by Globus Medical, a U.S.-based company specialized in ...
Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Globus Medical (NYSE:GMED) in the last three months. In the table below, you'll find a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results